We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




‘Lab on a Chip’ Paves Way for Use of Portable Spectrometer in Biomedical Analysis

By LabMedica International staff writers
Posted on 24 Oct 2022
Print article
Image: Light-analyzing ‘lab on a chip’ opens door to widespread use of portable spectrometers (Photo courtesy of Oregon State University)
Image: Light-analyzing ‘lab on a chip’ opens door to widespread use of portable spectrometers (Photo courtesy of Oregon State University)

Scientists have developed a better tool to measure light, contributing to a field known as optical spectrometry and resulting in a powerful, ultra-tiny spectrometer that fits on a microchip and is operated using artificial intelligence (AI). Traditional spectrometers require bulky optical and mechanical components, whereas the new device could fit on the end of a human hair. The research involved a comparatively new class of super-thin materials known as two-dimensional semiconductors, and the upshot is a proof of concept for a spectrometer that could be readily incorporated into a variety of technologies – including biomedical analyzers, among others.

The new research by scientists at Oregon State University (Corvallis, OR, USA) and Aalto University (Espoo, Finland) suggests those components can be replaced with novel semiconductor materials and AI, allowing spectrometers to be dramatically scaled down in size from the current smallest ones, which are about the size of a grape. The device is 100% electrically controllable regarding the colors of light it absorbs, which gives it massive potential for scalability and widespread usability, the researchers say. In medicine, spectrometers are already being tested for their ability to identify subtle changes in human tissue such as the difference between tumors and healthy tissue.

“We’ve demonstrated a way of building spectrometers that are far more miniature than what is typically used today,” said Ethan Minot, a professor of physics in the OSU College of Science. “Spectrometers measure the strength of light at different wavelengths and are super useful in lots of industries and all fields of science for identifying samples and characterizing materials. It’s exciting that our spectrometer opens up possibilities for all sorts of new everyday gadgets, and instruments to do new science as well.”

“Our spectrometer does not require assembling separate optical and mechanical components or array designs to disperse and filter light,” said Hoon Hahn Yoon, Aalto University. “Moreover, it can achieve a high resolution comparable to benchtop systems but in a much smaller package.”

Related Links:
Oregon State University
Aalto University

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.